ADR Sign up for ETOC alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Teleshova, N.
Right arrow Articles by Robbiani, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Teleshova, N.
Right arrow Articles by Robbiani, M.
Adv Dent Res 19:36-41, April, 2006
© 2006 International and American Associations for Dental Research

Dendritic Cells and HIV Infection: Activating Dendritic Cells to Boost Immunity

Presented at the Fifth World Workshop on Oral Health and Disease in AIDS, Phuket, Thailand, July 6–9, 2004, sponsored by Prince of Songkla University, Thailand, the International Association for Dental Research, the World Health Organization, the NIDCR/National Institutes of Health, USA, and the University of California-San Francisco Oral AIDS Center.

N. Teleshova#, J. Kenney, and M. Robbiani*

Center for Biomedical Research, Population Council, 1230 York Avenue, New York, NY 10021, USA

Correspondence: * corresponding author, mrobbiani{at}popcouncil.org

Dendritic cells (DCs) are white blood cells that coordinate innate and adaptive immunity. They are distributed within epithelia and mucosal-associated lymphoid tissues, positioned to entrap incoming pathogens or vaccines. Human immunodeficiency virus (HIV) and the non-human primate equivalent (SIV) exploit DCs to amplify infection, underscoring the need to harness strategies that promote presentation of virus by DCs to stimulate potent anti-viral immunity instead of virus transmission. Two main subsets of DCs need to be considered: myeloid (MDC) and plasmacytoid (PDC) subsets. Using the SIV-macaque system to advance oral vaccine research, we examined macaque PDC and MDC biology, identifying ways to activate DCs and boost antiviral immunity. Immunostimulatory oligodeoxyribonucleotides (ISS-ODNs) stimulated PDC/MDC mixtures to up-regulate co-stimulatory molecule expression and to secrete both IFN-{alpha} and IL-12. Additionally, ISS-ODNs augmented SIV-specific IFN-{gamma}responses induced by virus-bearing DCs. ISS-ODN-driven DC activation is being pursued to improve oral/nasopharyngeal mucosal vaccines and therapies against HIV.

KEY WORDS: Dendritic cells • immunostimulatory oligodeoxyribonucleotides • SIV • macaque • immunity




This article has been cited by other articles:


Home page
Adv. Dent. Res.Home page
M.C. Herzberg, A. Weinberg, and S.M. Wahl
(C3) The Oral Epithelial Cell and First Encounters with HIV-1
Adv. Dent. Res., April 1, 2006; 19(1): 158 - 166.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
IADR Journals Advances in Dental Research ®
Journal of Dental Research ® Critical Reviews (1990-2004)
Copyright © 2006 Institutional Access Guidelines